NCT04182880View on ClinicalTrials.gov

Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Abdominoplasty
Interventions
DRUG

CPL-01

CPL-01 will be administered

DRUG

Placebo

Placebo will be administered

Trial Locations (1)

21122

Chesapeake Research Group, Pasadena

Sponsors
All Listed Sponsors
lead

Cali Pharmaceuticals LLC

INDUSTRY